Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_assertion type Assertion NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_head.
- NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_assertion description "[Here, we hypothesize that variation in NFE2L2 and KEAP1, the genes encoding the two major regulators of the phase II response, may affect the risk of Parkinson's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_provenance.
- NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_assertion evidence source_evidence_literature NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_provenance.
- NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_assertion SIO_000772 20196834 NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_provenance.
- NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_assertion wasDerivedFrom befree-20140225 NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_provenance.
- NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_assertion wasGeneratedBy ECO_0000203 NP717540.RA6IHSILwPdPttqbwm5bxUU5iaQwhN8q3niMaB0suTj6E130_provenance.